PPD, Inc.

Pharmaceutical Product Development, Inc. today announced the completion of its acquisition by affiliates of The Carlyle Group and affiliates of Hellman & Friedman in an all-cash transaction valued ... read more

Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced that its shareholders have voted to approve the adoption of the agreement and plan of merger, dated October 2, 2011, ... read more

Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced the expiration of the 30-day “go-shop” period pursuant to the terms of the previously announced definitive merger agreement, entered into ... read more

Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced that it has entered into a definitive merger agreement under which it will be acquired by affiliates of The Carlyle ... read more

PPD, Inc. (Nasdaq: PPDI) today announced it has expanded its clinical microbiology laboratory at its global central laboratories worldwide, strengthening its laboratory ... read more

PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors has named Raymond H. Hill as PPD’s new chief executive officer and elected him to the board ... read more

PPD, Inc. (Nasdaq: PPDI) today announced it has been named to the 2011 InformationWeek 500, an annual list of the most innovative users of business technology in the ... read more

PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors has declared a cash dividend for the third quarter of 2011 under its annual cash dividend policy. ... read more

PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Jasmine (Jisong) Cui, Ph.D., as chief scientific officer of BioDuro, A PPD® Company. Dr. Cui will provide scientific leadership ... read more